HEALTH● LOWSep 7 · Sep 7, 2026, 9:22 PM
New evidence supports an Argentine treatment for cystic fibrosis in children and it is authorized from 2 years of age
Clarín · south america
Fue publicada en revistas científicas y además la ANMAT habilitó la triple terapia local para los más chicos.La función pulmonar aumentó un 20,8% tras el tratamiento y 13% la eliminación de secreciones.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH24m agoSPECIAL REPORT: Insecurity exposes Zamfara communities to recurring cholera outbreaksPremium TimesHEALTH1h agoAt NIFST AGM: NAFDAC DG charges food scientists on food safety, qualityVanguard NigeriaHEALTH1h agoAMR: FG warns of growing threat of drug-resistant infectionsVanguard NigeriaHEALTH1h agoUttar Pradesh MBBS doctors protest over pay disparity, pending salary arrears; announce work boycottThe Hindu